Zymeworks, Inc. (ZYME)
25.15
-0.81
(-3.12%)
USD |
NASDAQ |
Oct 02, 16:00
25.01
-0.14
(-0.56%)
After-Hours: 20:00
Zymeworks Net Income (Quarterly) : -45.02M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -45.02M |
| March 31, 2026 | -44.16M |
| December 31, 2025 | -41.21M |
| September 30, 2025 | -19.60M |
| June 30, 2025 | 2.317M |
| March 31, 2025 | -22.64M |
| December 31, 2024 | -23.51M |
| September 30, 2024 | -29.85M |
| June 30, 2024 | -37.69M |
| March 31, 2024 | -31.65M |
| December 31, 2023 | -14.48M |
| September 30, 2023 | -28.69M |
| June 30, 2023 | -51.15M |
| March 31, 2023 | -24.35M |
| December 31, 2022 | 309.43M |
| September 30, 2022 | -47.85M |
| June 30, 2022 | -64.62M |
| March 31, 2022 | -72.62M |
| December 31, 2021 | -39.15M |
| September 30, 2021 | -60.58M |
| June 30, 2021 | -67.52M |
| March 31, 2021 | -44.59M |
| December 31, 2020 | -37.89M |
| September 30, 2020 | -72.56M |
| June 30, 2020 | -38.96M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.14M |
| December 31, 2019 | -72.24M |
| September 30, 2019 | -30.48M |
| June 30, 2019 | -29.08M |
| March 31, 2019 | -13.64M |
| December 31, 2018 | 9.273M |
| September 30, 2018 | -18.75M |
| June 30, 2018 | -5.874M |
| March 31, 2018 | -21.20M |
| December 31, 2017 | 32.73M |
| September 30, 2017 | -16.24M |
| June 30, 2017 | -10.97M |
| March 31, 2017 | -15.93M |
| December 31, 2016 | -11.28M |
| September 30, 2016 | -12.40M |
| June 30, 2016 | -7.423M |
| March 31, 2016 | -2.712M |
| December 31, 2015 | -7.949M |
| September 30, 2015 | -5.812M |
| June 30, 2015 | -4.519M |
| March 31, 2015 | -0.89M |
| December 31, 2014 | -3.223M |
| September 30, 2014 | -3.514M |
| June 30, 2014 | -3.451M |
| March 31, 2014 | -2.754M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AbbVie, Inc. | 3.604B |
| Aprea Therapeutics, Inc. | -3.591M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Savara, Inc. | -40.23M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.59M |
| Total Expenses (Quarterly) | 49.61M |
| EPS Diluted (Quarterly) | -0.6168 |
| Enterprise Value | 1.808B |
| Gross Profit Margin (Quarterly) | 57.43% |
| Profit Margin (Quarterly) | -980.8% |
| Earnings Yield | -8.01% |
| Normalized Earnings Yield | -7.998 |